Manulife (Manufacturers Life Insurance)’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Buy |
+25,999
| New | +$167K | ﹤0.01% | 2625 |
|
|
2024
Q2 | – | Sell |
-95,570
| Closed | -$271K | – | 2965 |
|
|
2024
Q1 | $271K | Buy |
95,570
+9,922
| +12% | +$28.2K | ﹤0.01% | 2442 |
|
|
2023
Q4 | $1.26M | Buy |
85,648
+58,518
| +216% | +$861K | ﹤0.01% | 1689 |
|
|
2023
Q3 | $497K | Buy |
27,130
+6,299
| +30% | +$115K | ﹤0.01% | 2147 |
|
|
2023
Q2 | $449K | Buy |
20,831
+612
| +3% | +$13.2K | ﹤0.01% | 2111 |
|
|
2023
Q1 | $593K | Buy |
20,219
+83
| +0.4% | +$2.44K | ﹤0.01% | 1907 |
|
|
2022
Q4 | $744K | Buy |
+20,136
| New | +$744K | ﹤0.01% | 1755 |
|